Address & contact
https://www.ncis.com.sg/for-patients-and-visitors/for-international-patientsSpecialties
Reports that name this provider
- Cancer Screening Quality in Singapore
- Accepts international patient referrals for assessment and treatment. Provides community-based follow-up care for cancer survivors. International patients who have settled or returned for surveillance can access follow-up care.
- Chemotherapy & Immunotherapy Quality in Singapore
- Only public centre treating both paediatric and adult cancers under one roof, houses Chemotherapy Centre, Cellular Therapy Centre, and Radiotherapy Centre
- Clinical Trial Access in Singapore
- Part of NUHS cluster, maintains searchable list of actively recruiting oncology trials
- End-of-Life Counseling in Singapore
- Psychosocial Oncology service provides counseling for patients and families throughout the cancer journey
- Hyperthermia Treatment in Singapore
- Located at National University Hospital. Provides parallel HIPEC programme including clinical trial on Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) as palliative treatment for peritoneal disease.
- Integrative Oncology Quality in Singapore
- Attended NCCS Integrative Oncology Symposium in February 2025.
- Oncologic Surgery Quality in Singapore
- Operates Division of Surgical Oncology at National University Hospital covering 13 cancer types from brain to prostate. Hosted 3rd International Surgical Oncology Symposium in September 2024. Offers CRS/HIPEC procedures.
- Second Opinion Services in Singapore
- Co-leads multidisciplinary cancer management with NCCS. Coordinated sarcoma care initiative in April 2026 with input from 70 local and international clinicians. Co-operates IMPACT Molecular Tumour Board for precision oncology. Provides pre-arrival medical record review, visa support letters, airport transfers, and post-travel follow-up coordination.
- Stem Cell Therapy Availability in Singapore
- Comprehensive HSCT and CAR-T programme; has treated international patients from Vietnam and Australia; developed CD7 CAR-T therapy
- Stem Cell Therapy Quality in Singapore
- First programme in Asia to receive FACT accreditation for immune effector cell (IEC) therapy.